Radiolabeling brachytherapy sources with Re-188 through relating microfilms: Stents

Journal of Biomedical Materials Research

Volumn 53, Issue 3, 2000, Pages 244-251

  Zamora, Paul O ^a   Osaki, Shigemasa ^b   Som, Prantika ^a   Ferretti, John A ^c   Choi, Jeanie S ^c   Hu, Chen ze ^b   Tsang, Ray ^b   Kuan, Hsin M ^c   Singletary, Sylvia ^c   Stern, Robert A ^b   Oster, Zvi H ^c  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b InnerDyne Inc   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

Brachytherapy; Chelate; Radiolabeling; Rhenium 188; Stents

Indexed keywords

RHENIUM 188; SILOXANE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY; ARTICLE; BRACHYTHERAPY; CHELATION; CONTROLLED STUDY; ISOTOPE LABELING; MICROFILM; NONHUMAN; RADIATION DOSE; RADIOACTIVITY; STENT; SWINE;

BIOCOMPATIBLE MATERIALS; BRACHYTHERAPY; CHELATING AGENTS; HUMANS; ISOTOPE LABELING; RADIOISOTOPES; RHENIUM; STENTS;

EID: 0034039241     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(2000)53:3<244::AID-JBM9>3.0.CO;2-F     Document Type: Article

References (36)

1. Sauer R. Interventional radiation therapy: techniques brachytherapy. Berlin: Springer-Verlag; 1991.
2. Stitt JA, Thomadsen BR. Innovations and advances in brachytherapy. Semin Oncol 1997;24:696-706.
3. Diamond DA, Vesely TM. The role of radiation therapy in the management of vascular restenosis. Part I. Biologic basis. J Vase Interv Radiol 1998;9:199-208.
4. Diamond DA, Vesely TM. The role of radiation therapy in the management of vascular restenosis. Part II. Radiation techniques and results. J Vase Interv Radiol 1998;9:389-400.
5. Condado JA, Waksman R, Gurdiel O, Espinosa R, Gonzalez J, Buerger B, Villoria G, Aquatella H, Crocker IR, Seung KB, Liprie SF. Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans. Circulation 1997;96:727-732.
6. rd, Williams DO, Chougule P, Klein JL, Waksman R, Hilstead R, Macdonald J, Anderberg K, Crocker IR. Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty: results of the beta energy restenosis trial (BERT). Circulation 1998;97:2025-2030.
7. rd. Efficacy of beta radiation in prevention of post-angioplasty restenosis. An interim report from the beta energy restenosis trial. Herz 1998; 23:356-361.
8. Teirstein PS, Massullo V, Jani S, Popma JJ, Mintz GS, Russo RJ, Schatz RA. Guarneri EM, Steuterman S, Morris NB, Leon MB, Tripuraneni P. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997;336:1697-1703.
9. Waksman R, Rodriguez, JC, Robinson KA, Cipolla GD, Crocker IR, Scott NA, King SB 3rd, Wilcox JN. Effect of intravascular irradiation on cell proliferation, apoptosis, and vascular remodeling after balloon overstretch injury of porcine coronary arteries. Circulation 1997;96:1944-1952.
10. Carter AJ, Laird JR, Bailey LR, Hoopes TG, Farb A, Fischell DR, Fischell FE, Fischell TA, Virmani R. Effects of endovascular radiation from a beta-particle-emitting stent in a porcine coronary restenosis model. A dose-response study. Circulation 1996;94:364-368.
11. Carter AJ, Laird LR. Experimental results with endovascular irradiation via a radioactive stent. Int J Radiat Oncol Biol Phys 1996;36:797-803.
12. Hehrlein C, Stintz M, Kinscherf R, Schlosser K, Huttel E, Friedrich L, Fehsenfeld P, Kubler W. Pure beta-particle-emitting stents inhibit neointima formation in rabbits. Circulation 1996;93:641-645.
13. Hehrlein C, Gollan C, Donges K, Metz J, Riessen R, Fehsenfeld P, von Hodenberg E, Kubler W. Low-dose radioactive endovascular stents prevent smooth muscle cell proliferation and neointimal hyperplasia in rabbits. Circulation 1995;2:1570-1575.
14. Eigler NL, Li AN, Whiting JS, DeFrance A. A vanadium-48 brachytherapy source for treatment of coronary restenosis. Chapter 23. In: R Waxman, SB King, IR Crocker, RF Mould, editors. Vascular brachytherapy. Nucleotron; 1996.
15. Johnson LS, Yanch JC, Shortkroff S, Barnes CL, Sledge CB. Beta-particle dosimetry in radiation synovectomy. Euro J Nucl Med 1995;22:977-988.
16. Knapp FF Jr, Beets AL, Guhlke S, Zamora PO, Bender H. Palmedo H, Biersack HJ. Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatment. Anticancer Res 1997;17:1783-1795.
17. Hu EK, Dolence C-Z, Osaki S, Sanders CG. Hydrocyclosiloxane membrane prepared by plasma polymerization process. US Patent #5463010, 1995.
18. Dolence EK, Hu C-Z, Tsang R, Sanders CG, Osaki S. Electrophilic polyethylene oxides for the modification of polysaccharides. polypeptides (proteins) and surfaces. US Patent #5650234, 1997.
19. Zamora PO, Ferretti JA, Som P, Choi J, Osaki S, Kuan P, Singletary S, Stern RA, Z Oster. On-demand labeling of metal stents with Re-188 for use in treating restenosis. J Nucl Med 1999.
20. Joiris E, Bastin B, Thornback JR. A new method for labeling of monoclonal antibodies and their fragments with technetium-99m. Int J Rad Appl Instrum [B] 1991;18:353-356.
21. 99mTc and in vivo localization following intracerebral injection into normal and glioma-bearing rats. Bioconjug Chem 1997;8: 289-295.
22. 188Re-RC160, a directly-radiolabeled somatostatin analog. Int J Cancer 1996;65: 214-220.
23. Blower PJ, Lam ASK, O'Doherty MJ, Kettle AG. Coakley AJ. Knapp FF Jr. Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies. Euro J Nucl Med 1998;6:613-621.
24. Juweid M, Sharkey RM, Swayne LC, Griffiths GL, Dunn R, Goldenberg DM. Pharmacokinetics, dosimetry and toxicity of rhenium-188-labeled anti-carcinoetnbryonic antigen monoclonal antibody, MN-14, in gastrointestinal cancer. J Nucl Med 1998;39:34-42.
25. McMurry TJ, Pippin CG, Wu C, Deal KA, Brechbiel MW, Mirzadeh S, Gansow OA. Physical parameters and biological stability of yttrium(III) diethylenetriaminepentaacetic acid derivative conjugates. Med Chem 1998;41:3546-3549.
26. Kobayashi H, Wu C, Yoo TM, Sun BF, Drumm D, Pastan I, Paik CH, Gansow OA, Carrasquillo JA, Brechbiel MW. Evaluation of the in vivo biodistribution of yttrium-labeled isomers of CHX-DTPA-conjugated monoclonal antibodies. J Nucl Med 1998;39:829-836.
27. Camera L, Kinuya S, Garmestani K, Brechbiel MW, Wu C, Pai LH, McMurry TJ, Gansow OA, Pastan I, Paik CH, et al. Comparative biodistribution of indium-and yttrium-labeled B3 monoclonal antibody conjugated to either 2-(p-SCN-Bz)-6-methyl-DTPA (1B4M-DTPA) or 2-(p-SCN-Bz)-1,4,7,10-tet-raazacyclododecane tetraacetic acid (2B-DOTA). Euro J Nucl Med 1994;21:640-664.
28. 99mTc-MAG3 as prosthetic groups for labeling amines and peptides: approaches with pre-and postconjugate labeling. Nucl Med Biol 1998;25: 621-631.
29. Hafeli UO, Warburton MC, Landau U. Electrodeposition of radioactive rhenium onto stents to prevent restenosis. Biomater 1998;19:925-933.
30. Eary JF, Durack L, Williams D, Vanderheyden JL. Considerations for imaging Re-188 and Re-186 isotopes. Clin Nucl Med 1990;15:911-916.
31. Weinberger J. Intracoronary radiation using radioisotope solution-filled balloons. Herz 1998;S6:366-372.
32. 188Re in a balloon catheter. Nucl Med Commun 1998;19:795-801.
33. Knapp FF Jr, Guhlke S, Beets AL, et al. Intraarterial irradiation with rhenium-188 for inhibition of restenosis after PTCA -strategy and evaluation of species for rapid urinary excretion. J Nucl Med 1997;38:124.
34. Fontaine AB, Koelling K, Clay J, Spigos DG, Dos Passos S, Christoforidis G, Hinkle G, Hill T, Cearlock J, Pozderac R. Decreased platelet adherence of polymer-coated tantalum stents. J Vase Interv Radiol 1994;5:567-572.
35. Fontaine AB, Koelling K, Passos SD, Cearlock J, Hoffman R, Spigos DG. Polymeric surface modifications of tantalum stents. J Endovasc Sur 1996;3:276-283.
36. van der Giessen WJ, Lincoff AM, Schwartz RS, van Beusekom HM, Serruys PW, Holmes DR Jr, Ellis SG, Topol EJ. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996;94:1690-1697.